SCHEMBL31662200

SCHEMBL31662200

C=CCOc1nc(Cl)c(F)c2nc(SC)nc(O)c12

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26709510 0.85 MAPT (0.34) MEN1KMT2A
SCHEMBL27138690 0.81 L3MBTL1 (0.32) MEN1KMT2A
SCHEMBL26709392 0.78 LMNA (0.34)
SCHEMBL31103528 0.78
SCHEMBL31662213 0.78 LMNA (0.34)
SCHEMBL30743024 0.77
SCHEMBL31662326 0.77 ACACB (0.31)
SCHEMBL30742983 0.77
SCHEMBL30832332 0.77
SCHEMBL27311619 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025151594-A1 FUSED AZINES AS RAS INHIBITORS AND METHODS OF USE THEREOF KESTREL THERAPEUTICS INC. (US) 2025-07-17 WO disclosed